Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.50.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.15SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.14.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.14.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1 (Omicron)SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.17.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
JN.1.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
ME.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.1.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.21.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.17.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.13.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.1.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
XFSYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
XSSYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
B.1.258.22SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BC.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.22SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.1 (Omicron)SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
JN.1.50SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.1.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.1.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.1.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.1.15SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BD.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.14SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
B.1.525 (Eta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.16.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.23SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BC.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.1.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.3 (Omicron)SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.1.16.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13443.5Singapore
BA.2 (Omicron)SChan-SCAAGCTATAACGCAGCCTGTA2147.622286922849R-13440.2China
B.1.258.17ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-13419.5Japan
AY.33 (Delta)ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-13363.1France
FR.1ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-13363.1France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used